Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial

Published:2014-11 Issue:6 Volume:8 Page:554-561
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Moriarty Patrick M.,Jacobson Terry A.,Bruckert Eric,Thompson Paul D.,Guyton John R.^ORCID,Baccara-Dinet Marie T.^ORCID,Gipe Daniel^ORCID

Funder

Sanofi

Regeneron Pharmaceuticals, Inc.

Amgen

Kowa

Lilly

Novartis

Regeneron Pharmaceuticals, Inc

Genzyme

Pfizer

Catabasis

Esperion

B. Braun

Kaneka

Amarin

Danone

Unilever

NHLBI

NIAMS

NCCAM

Genomas

Roche

Sanolfi

Regeneron

Abbott

GlaxoSmithKline

Amarin Pharma

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines;Stone;J Am Coll Cardiol,2013

2. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update;Mancini;Can J Cardiol,2013

3. An assessment by the Statin Muscle Safety Task Force: 2014 update;Rosenson;J Clin Lipidol,2014

4. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education;Wei;J Clin Lipidol,2013

5. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients–the PRIMO study;Bruckert;Cardiovasc Drugs Ther,2005

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association;Diabetes & Metabolism Journal;2024-07-31

2. Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators;Journal of Diabetes Investigation;2024-04-27

3. The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy;Biomedicines;2024-04-26

4. Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation;European Heart Journal - Cardiovascular Pharmacotherapy;2024-04-20

5. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11